<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00756548</url>
  </required_header>
  <id_info>
    <org_study_id>BLI850-302</org_study_id>
    <secondary_id>BLI850-302</secondary_id>
    <nct_id>NCT00756548</nct_id>
  </id_info>
  <brief_title>BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy</brief_title>
  <official_title>BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA
      approved bowel preparation in adult subjects undergoing colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy - Preparation Quality Using a 4 Point Scale</measure>
    <time_frame>2 days</time_frame>
    <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (mEq/L)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results (%)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (U/L)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (mg/dL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (g/dL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results - Glomerular Filtration Rate</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results - Hemoglobin</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results (1000/MCL)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematology Results - Red Blood Cells</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Chemistry Results (Osmolality)</measure>
    <time_frame>2 days</time_frame>
    <description>Change from Baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">386</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BLI850</intervention_name>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyethylene glycol 3350 based bowel preparation</intervention_name>
    <description>multi-dose preparation for oral administration prior to colonoscopy</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted
             indication, including:

               -  Evaluation of barium enema results

               -  GI bleeding

               -  Anemia of unknown etiology

               -  Neoplastic disease surveillance

               -  Abnormal Endosonography

               -  Inflammatory bowel disease

               -  Unknown diarrhea or constipation etiology

               -  Polypectomy

               -  Laser therapy

               -  Routine screening

          2. At least 18 years of age.

          3. Otherwise in good health, as determined by physical exam and medical history.

          4. If female, and of child-bearing potential, is using an acceptable form of birth
             control (hormonal birth control, intra-uterine device, double-barrier method, depot
             contraceptive, abstinent, or vasectomized spouse).

          5. Negative urine pregnancy test at screening, if applicable.

          6. In the Investigator's judgment, subject is mentally competent to provide informed
             consent to participate in the study.

        Exclusion Criteria:

          1. Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal
             obstruction, gastric retention, bowel perforation, toxic colitis, or megacolon.

          2. Subjects with impaired consciousness that predisposes them to pulmonary aspiration.

          3. Subjects who are undergoing colonoscopy for foreign body removal or decompression.

          4. Subjects with clinically significant electrolyte abnormalities based on Visit 1
             laboratory results.

          5. Subjects who had previous significant gastrointestinal surgeries (e.g. colostomy,
             colectomy, gastric bypass).

          6. Subjects who are pregnant or lactating, or intending to become pregnant during the
             study.

          7. Subjects of childbearing potential who refuse a pregnancy test.

          8. Subjects who are allergic to any preparation components

          9. Subjects who, in the opinion of the Investigator, should not be included in the study
             for any reason, including inability to follow study procedures.

         10. Subjects who have participated in an investigational surgical, drug, or device study
             within the past 30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Advanced Clinical Research Institute</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research Institute</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92869</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Associates</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Options Health Research</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Gastroenterology Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franklin Gastroenterology</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memphis Gastroenterology Group</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Frist Clinic</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Medical Research Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlottesville Medical Research</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Gastroenterology Associates</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2008</study_first_submitted>
  <study_first_submitted_qc>September 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2008</study_first_posted>
  <results_first_submitted>February 19, 2013</results_first_submitted>
  <results_first_submitted_qc>December 3, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 27, 2013</results_first_posted>
  <disposition_first_submitted>November 16, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>November 16, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">November 18, 2009</disposition_first_posted>
  <last_update_submitted>December 3, 2013</last_update_submitted>
  <last_update_submitted_qc>December 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <keyword>screening</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>386 subjects were randomized. 15 patients did not take the preparation are were excluded from the Intent-to-treat population.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>BLI850</title>
          <description>single administration oral preparation - split dose</description>
        </group>
        <group group_id="P2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          <description>single administration oral preparation - split dose</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="186"/>
                <participants group_id="P2" count="185"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="184"/>
                <participants group_id="P2" count="185"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intent-to-treat population</population>
      <group_list>
        <group group_id="B1">
          <title>BLI850</title>
        </group>
        <group group_id="B2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="186"/>
            <count group_id="B2" value="185"/>
            <count group_id="B3" value="371"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="136"/>
                    <measurement group_id="B3" value="280"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.9" spread="11.4"/>
                    <measurement group_id="B2" value="56.8" spread="11.0"/>
                    <measurement group_id="B3" value="56.9" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="186"/>
                    <measurement group_id="B2" value="185"/>
                    <measurement group_id="B3" value="371"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Efficacy - Preparation Quality Using a 4 Point Scale</title>
        <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;)</description>
        <time_frame>2 days</time_frame>
        <population>186 patients were included in the BLI850 intent-to-treat population. One patient took the preparation but did not undergo colonoscopy due to insurance coverage issues. This patient is excluded from all efficacy analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Efficacy - Preparation Quality Using a 4 Point Scale</title>
          <description>Percentage of patients with a successful preparation (cleaning rated as &quot;Good&quot; or &quot;Excellent&quot;)</description>
          <population>186 patients were included in the BLI850 intent-to-treat population. One patient took the preparation but did not undergo colonoscopy due to insurance coverage issues. This patient is excluded from all efficacy analyses.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="185"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="89" upper_limit="97"/>
                    <measurement group_id="O2" value="94" lower_limit="89" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (mEq/L)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (mEq/L)</title>
          <description>Change from Baseline</description>
          <units>milliequivalent/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anion Gap (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="3.21"/>
                    <measurement group_id="O2" value="0.92" spread="2.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bicarbonate (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="2.9"/>
                    <measurement group_id="O2" value="-1.69" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="2.6"/>
                    <measurement group_id="O2" value="1.58" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.12"/>
                    <measurement group_id="O2" value="-0.04" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.43"/>
                    <measurement group_id="O2" value="-0.11" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium (mEq/L)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="2.4"/>
                    <measurement group_id="O2" value="0.81" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results (%)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results (%)</title>
          <description>Change from Baseline</description>
          <population>Intent to treat population</population>
          <units>Percentage of cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Basophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.48"/>
                    <measurement group_id="O2" value="-0.01" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.98"/>
                    <measurement group_id="O2" value="-0.08" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematocrit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="2.9"/>
                    <measurement group_id="O2" value="0.33" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.83" spread="6.4"/>
                    <measurement group_id="O2" value="0.05" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Monocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="1.87"/>
                    <measurement group_id="O2" value="0.07" spread="1.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="7.3"/>
                    <measurement group_id="O2" value="-0.03" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (U/L)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (U/L)</title>
          <description>Change from Baseline</description>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Alkaline phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="10.5"/>
                    <measurement group_id="O2" value="0.67" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.34" spread="23.9"/>
                    <measurement group_id="O2" value="3.86" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Amylase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.98" spread="11.8"/>
                    <measurement group_id="O2" value="-6.55" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.11" spread="8.4"/>
                    <measurement group_id="O2" value="4.22" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine kinase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="72"/>
                    <measurement group_id="O2" value="4.2" spread="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GGT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="6.6"/>
                    <measurement group_id="O2" value="1.95" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (mg/dL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (mg/dL)</title>
          <description>Change from Baseline</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blood urea nitrogen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.91" spread="3.9"/>
                    <measurement group_id="O2" value="-3.01" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.46"/>
                    <measurement group_id="O2" value="-0.17" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.14"/>
                    <measurement group_id="O2" value="0.00" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Direct bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.07"/>
                    <measurement group_id="O2" value="0.04" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.78" spread="24"/>
                    <measurement group_id="O2" value="-4.98" spread="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.62"/>
                    <measurement group_id="O2" value="-0.13" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.34"/>
                    <measurement group_id="O2" value="0.15" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.74"/>
                    <measurement group_id="O2" value="0.00" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (g/dL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (g/dL)</title>
          <description>Change from Baseline</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.22"/>
                    <measurement group_id="O2" value="0.05" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total protein</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.34"/>
                    <measurement group_id="O2" value="0.10" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results - Glomerular Filtration Rate</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results - Glomerular Filtration Rate</title>
          <description>Change from Baseline</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.53" spread="12.6"/>
                    <measurement group_id="O2" value="-0.23" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results - Hemoglobin</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results - Hemoglobin</title>
          <description>Change from Baseline</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.72"/>
                    <measurement group_id="O2" value="0.12" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results (1000/MCL)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results (1000/MCL)</title>
          <description>Change from Baseline</description>
          <units>1000/MCL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Platelets</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="38"/>
                    <measurement group_id="O2" value="-1.00" spread="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White Blood Cells</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.39" spread="1.65"/>
                    <measurement group_id="O2" value="-0.48" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hematology Results - Red Blood Cells</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Hematology Results - Red Blood Cells</title>
          <description>Change from Baseline</description>
          <units>million/microliter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.24"/>
                    <measurement group_id="O2" value="0.03" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Chemistry Results (Osmolality)</title>
        <description>Change from Baseline</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BLI850</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
          <group group_id="O2">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>multi-dose preparation for oral administration</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Chemistry Results (Osmolality)</title>
          <description>Change from Baseline</description>
          <units>mOsm/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="186"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.12" spread="8.6"/>
                    <measurement group_id="O2" value="-0.11" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>BLI850</title>
        </group>
        <group group_id="E2">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="185"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>abdominal cramping</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="185"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="155" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="147" subjects_at_risk="185"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="96" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="112" subjects_at_risk="185"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="79" subjects_at_risk="185"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="185"/>
              </event>
              <event>
                <sub_title>Overall discomfort</sub_title>
                <counts group_id="E1" subjects_affected="116" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="121" subjects_at_risk="185"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="186"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="185"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extent the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John McGowan, Director, Clinical Research</name_or_title>
      <organization>Braintree Laboratories, Inc.</organization>
      <phone>781-843-2202</phone>
      <email>jmcgowan@braintreelabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

